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Abstract
Background: Progressive remodeling of the left ventricle (LV) following myocardial infarction (MI) can lead to
congestive heart failure, but the underlying initiation factors remain poorly defined. The objective of this study,
accordingly, was to determine the key factors and elucidate the regulatory mechanisms of LV remodeling using
integrated computational and experimental approaches.
Results: By examining the extracellular matrix (ECM) gene expression and plasma analyte levels in C57/BL6J mice
LV post-MI and ECM gene responses to transforming growth factor (TGF-b1) in cultured cardiac fibroblasts, we
found that key factors in LV remodeling included macrophages, fibroblasts, transforming growth factor-b1, matrix
metalloproteinase-9 (MMP-9), and specific collagen subtypes. We established a mathematical model to study LV
remodeling post-MI by quantifying the dynamic balance between ECM construction and destruction. The
mathematical model incorporated the key factors and demonstrated that TGF-b1 stimuli and MMP-9 interventions
with different strengths and intervention times lead to different LV remodeling outcomes. The predictions of the
mathematical model fell within the range of experimental measurements for these interventions, providing
validation for the model.
Conclusions: In conclusion, our results demonstrated that the balance between ECM synthesis and degradation,
controlled by interactions of specific key factors, determines the LV remodeling outcomes. Our mathematical
model, based on the balance between ECM construction and destruction, provides a useful tool for studying the
regulatory mechanisms and for predicting LV remodeling outcomes.
Background
Myocardial infarction (MI) is a leading cause of conges-
tive heart failure (CHF) [1,2]. In response to the MI sti-
mulus, the left ventricle (LV) undergoes structural and
functional adaptations that collectively have been termed
as LV remodeling [3]. Adverse LV remodeling pro-
gresses to CHF in about 25% of post-MI patients, but
the mechanisms that drive this progression remain
poorly understood. During LV remodeling, both extra-
cellular matrix (ECM) degradation and synthesis
increase [4]. When ECM degradation dominates over
synthesis, LV rupture can occur. When ECM synthesis
dominates over degradation rates, fibrosis can occur.
Fibrosis increases myocardial stiffness and further
depresses LV function to culminate in CHF [5,6]. There-
fore, understanding what regulates the balance between
ECM degradation and synthesis post-MI is critical to
understand the mechanisms of LV remodeling and may
allow us to target specific early diagnostic indicators to
better guide treatment protocols.
Previous studies have shown that matrix metallopro-
teinases (MMPs) regulate ECM degradation and fibro-
blasts regulate ECM synthesis [7-9]. MMP-9,
transforming growth factor-b1 (TGF-b1), tissue inhibitor
of metalloproteinase-1 (TIMP-1), and collagen I levels
are significantly elevated from day 1 to day 7 post-MI
[4,10,11]. These increases are concomitant with
increased infiltration of macrophages and activation of
fibroblasts [12]. LV remodeling is a complex process
that involves the spatiotemporal interactions among
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stood, in part due to the lack of complete sets of experi-
mental data and computationa lm o d e l s .T h e r e f o r e ,t h e
objectives of this study were to 1) identify candidate bio-
markers of LV remodeling post-MI from ECM gene
expression and plasma analyte analyses, and 2) establish
a mathematical model that incorporates experimental
results to predict LV remodeling outcomes following
different interventions. This model would provide a tool
to elucidate LV regulatory mechanisms, estimate un-
measurable variables, and predict outcomes following
multiple therapeutic scenarios.
Results
Identifying Key Factors
T h ek e yf a c t o r sw e r ep r e - t a r g e t e db ye x a m i n i n gt h e
most significant changes in ECM gene expression in the
infarct region at day 7 post-MI, compared to gene
expression in the remote non-infarcted region of the
same LV and in the LV from control group. In the
ECM gene array analysis, total RNA yield was 1.0 ± 0.1,
1.9 ± 0.2, and 2.9 ± 0.3 μg/mg LV tissue for control,
remote, and infarct samples, respectively (p < 0.05 for
control vs remote and infarct, and for remote vs infarct).
Of the 84 genes examined, 51 genes were differentially
expressed among control, remote, and infarcted groups
(all p < 0.05). The most prevalent pattern of gene
expression changes was an increased expression level in
the infarct tissue, compared to both control and remote
groups. Of the 51 genes, 17 genes showed > 2.5-fold
change in the infarct region, and these genes are listed
in Table 1. Of the 17 genes with >2.5-fold change, the
most significantly over expressed genes are cadherin 3,
collagen 1, collagen 2, and collagen 3, osteopontin, peri-
ostin, tissue inhibitor of metalloproteinase-1, fibronectin,
secreted protein acidic and rich in cysteine (SPARC),
and transforming growth factor-b. From this list, col-
lagen I was selected as a key factor, because it is the
major collagen in the normal LV, accounting for 90% of
cardiac ECM. Osteopontin expression levels increased
206-fold in the infarct region compared to the control
group, suggesting strong macrophage activation at day 7
post-MI. TIMP-1 expressions increased 31-fold in the
infarct compared to the control group, suggesting strong
inhibition of proteolytic activity. Periostin gene expres-
sion level was increased 5.5-fold, and TGF-b1g e n e
expression level was increased 2.6-fold in the infarct
sample at day 7, suggesting significant fibroblast func-
tions post-MI [13-16].
We further examined plasma profiles at day 7 post-MI
to determine if gene level changes were mirrored in the
post-MI plasma. In the plasma profiles, 11 proteins
increased in the day 7 post-MI samples (Table 2). Of
these, increased MMP-9 and TIMP-1 indicate changes
in ECM remodeling. There were several proteins that
influence macrophage activation and function, including
macrophage inflammatory protein-1 and osteopontin
that increased in post-MI plasma. Via analysis of the
plasma changes post-MI [4,7-12], we further confirmed
key factors involved in macrophage and fibroblast func-
tions, namely collagen I, MMP-9, and TIMP-1.
In addition, we examined the ECM productions in iso-
lated cardiac fibroblasts stimulated with TGF-b1.F i b r o -
b l a s tE C Ma r r a ya n a l y s i ss h o w e dt h a tT G F - b1
stimulation of cardiac fibroblasts up regulated 5 genes
and down regulated 7 genes, which are shown in Table
3. Collagen I expression and SPARC expression levels
were doubled, and TIMP-1 expression increased 5-fold
in response to TGF-b1 stimulation at the concentration
of 10 ng/mL. These experimental data indicated a pri-
mary regulatory effect of TGF-b1 on fibroblast ECM
production. Interestingly, the 5 up regulated genes are
among the 17 ECM genes that were significantly
expressed in the LV, indicating that the cardiac fibro-
blast is likely the major tissue source for these ECM
genes (Table 1).
We also examined the correlations between LV wall
thickness with 6 genes that were over expressed post-
MI. The R
2 values were 0.76 for collagen 1a1, 0.64 for
collagen 2a1, 0.75 for collagen 5a1, 0.60 for periostin,
0.61 for osteopontin, and 0.63 for TGF-b1.
In summary, the key factors identified were macro-
phages, fibroblasts, TGF-b1,M M P - 9 ,a n dc o l l a g e n .
Based on these experimental results, we developed a
Table 1 ECM Gene Array (Data are Mean ± SD normalized
levels.)
Gene Control Remote Infarct
Cdh3 1.0E-05 ± 9.8E-06 7.4E-05 ± 5.5E-05 2.8E-04 ± 1.3E-04
Col1a1 1.5E-02 ± 2.6E-03 1.9E-01 ± 1.0E-01 8.2E-01 ± 3.4E-01
Col2a1 3.1E-06 ± 6.3E-07 1.1E-05 ± 1.1E-05 2.3E-04 ± 1.8E-04
Col3a1 5.0E-03 ± 1.5E-03 8.0E-02 ± 5.5E-02 2.3E-01 ± 9.7E-02
Col5a1 8.0E-3 ± 2.0E-3 2.3E-2 ± 1.1E-2 4.1E-2 ± 1.6E-2
Ctgf 2.5E-02 ± 4.3E-03 7.6E-02 ± 5.0E-02 1.7E-01 ± 9.1E-02
Fn1 9.0E-03 ± 2.5E-03 4.3E-02 ± 2.7E-02 1.6E-01 ± 6.9E-02
Mmp2 3.5E-03 ± 1.2E-03 1.2E-02 ± 7.9E-03 1.8E-02 ± 7.5E-03
Mmp14 1.9E-03 ± 4.6E-04 6.8E-03 ± 3.2E-03 1.5E-02 ± 6.8E-03
Ncam1 6.2E-04 ± 1.3E-04 1.8E-03 ± 1.3E-03 4.1E-03 ± 1.7E-03
Postn 5.3E-03 ± 1.6E-03 1.5E-01 ± 9.2E-02 2.9E-01 ± 1.2E-01
Sparc 1.3E-02 ± 3.7E-03 7.0E-02 ± 3.7E-02 1.1E-01 ± 4.5E-02
Spp1 1.3E-05 ± 5.7E-06 3.1E-04 ± 4.5E-04 2.6E-03 ± 2.2E-03
Tgfbi 2.0E-03 ± 3.3E-04 3.3E-03 ± 1.2E-03 7.1E-03 ± 3.6E-03
Thbs1 7.2E-03 ± 6.7E-03 1.2E-02 ± 7.6E-03 4.0E-02 ± 1.6E-02
Thbs2 9.0E-03 ± 2.3E-03 1.1E-02 ± 3.6E-03 3.9E-02 ± 1.4E-02
Timp1 2.0E-04 ± 9.4E-05 4.1E-03 ± 3.1E-03 6.1E-03 ± 3.3E-03
Control is unoperated mice; MI is 7d post-MI mice.
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key factors (Figure 1).
Linking Experimental Results to Mathematical Modeling
Framework
In the ECM construction pathway, collagen is secreted
by fibroblasts. Growth and secretion of fibroblasts are
stimulated by TGF-b1 (Table 3). In ECM destruction
pathway, MMP-9 is a key factor by cleaving collagen.
The major source of MMP-9 is the macrophage, which
infiltrates into the infarct region post-MI. The majority
of macrophages in the LV post-MI are differentiated
from peripheral blood monocytes stimulated by che-
moattractants including TGF-b1 [17]. The major source
of TGF-b1 is the macrophage. Meanwhile, there are
interactions between the ECM construction and destruc-
tion pathways: a) MMP-9 regulates ECM construction
by activating TGF-b1 which stimulates collagen synth-
esis; b) TGF-b1 induces TIMP-1, which inhibits collagen
degradation by blocking MMP-9 activity. Linking these
key factors with their sources and effects allows us to
develop the mathematical model for quantitative
analysis.
Mathematical Modeling
We established a set of nonlinear differential equations
to model the temporal interactions among the key fac-
tors identified by our experimental results. The model
incorporated the following variables: macrophage cell
density (MF, cells/mm
3), fibroblast cell density (F, cells/
mm
3), collagen concentration (C, μg/μL), TGF-b1 con-
centration (Tb, pg/μL), and activated MMP-9 concentra-
tion (M9A,p g / μL). Rates of cell number change were
determined by the summation of constructive effects
(migration rate or proliferation rate) and destructive
effects (death rate or removal rate). Rates of chemical
factors (TGF-b1, MMP-9, collagen, etc) change were
determined by the net difference between the synthesis
rate and degradation rate.
Four assumptions were used based on experimental
results: 1) All monocytes that migrate to the infarct
region are differentiated to macrophages [18]; all acti-
vated macrophages are differentiated from peripheral
blood monocytes since previous studies have shown that
<5% of macrophages undergo mitotic division [19]; 2)
The major source of fibroblasts is the resident cell and
the contribution of circulating fibroblasts is ignored
[20]; 3) The majority (80%) of TGF-b1 secreted at the
injured site becomes activated [21,22]; 4) ECM proteins
in the infarct region are secreted by local cells. Our
experimental data showed that ECM gene expression
was higher in the infarct region than the expression in
the remote region, and ECM gene levels in the remote
Table 2 Multi-analyte Profiling of Control and 7 day Post-MI Plasma
Control n = 6 7 d MI n = 7 P value
Clusterin (μg/mL) 330 ± 40 510 ± 200 0.046
Cystatin-C (ng/mL) 360 ± 20 530 ± 100 0.008
Eotaxin (pg/mL) 1500 ± 200 1900 ± 400 0.049
Fibrinogen (mg/mL) 12 ± 2 19 ± 5 0.012
Haptoglobin (μg/mL) 83 ± 30 180 ± 50 0.002
Macrophage Inflammatory Protein-1 gamma (ng/mL) 24 ± 4 33 ± 9 0.042
Matrix Metalloproteinase-9 (ng/mL) 71 ± 9 96 ± 20 0.009
Myeloperoxidase (ng/(mL) 58 ± 10 100 ± 30 0.006
Osteopontin (ng/mL) 250 ± 60 390 ± 100 0.041
Serum Amyloid Protein (μg/mL) 21 ± 3 33 ± 9 0.013
TIMP-1 (ng/mL) 0.8 ± 0.1 3.7 ± 2.0 0.002
Table 3 Fibroblast ECM array in serum free control and
10 ng/ml TGF-b stimulated fibroblasts
Serum Free TGF-b p Value
ECM/Growth Factors
Col1a1 4.842 ± 1.399 9.614 ± 3.324 0.028
Col5a1 0.301 ± 0.085 0.605 ± 0.230 0.038
Fbln1 0.012 ± 0.005 0.008 ± 0.004 0.032
Sparc 2.709 ± 0.204 4.932 ± 0.379 <0.001
Tgfbi 0.022 ± 0.016 0.013 ± 0.015 0.009
Cell Adhesion Molecules
Ncam1 0.043 ± 0.016 0.169 ± 0.054 0.011
Pecam1 0.000060 ± 0.000012 0.000022 ± 0.000011 0.015
Sgce 0.187 ± 0.035 0.146 ± 0.018 0.030
Vcam1 0.301 ± 0.136 0.161 ± 0.088 0.031
MMPs/TIMPs
Mmp7 0.0000075 ± 0.0000011 0.0000056 ± 0.0000004 0.026
Timp1 0.052 ± 0.022 0.272 ± 0.136 0.035
Timp2 0.326 ± 0.109 0.188 ± 0.050 0.027
Data are Avg ± SEM levels (2
-ΔCT) normalized to 5 housekeeping genes for n =
4 paired fibroblast sets.
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cating a local source of ECM production.
Accordingly, the scar formation post-MI was modeled
by the following set of differential equations
M 
φ =
infiltration
  
M(Tβ) −
removal
  
dM M ,
(1)
kcrowding = kmem(t)+M /ρM  + F/ρF + C/ρC, (2)
F  =
ﬁbroblast proliferation rate with crowding effect
  
kFFg(Tβ) F[1 − kcrowding] −
apoptosis

dFF ,
(3)
T 
β =
M  secretion
  
kM TM  +
ﬁbroblast
secretion 
kFTF +
TGFβ
activation 
uT −
degradation
  
dTβTβ ,
(4)
M9A +C
kon ←→
koff
[CM9]
konc − − → CID + MMP9 (5a)
M 
9A =
secretion by M    
kM M9M 
activation by TGF−β

h(T)+
ocupied for collagen degradation
  
koff[CM9] − konM9AC −
inactivation
  
dM9M9A, (5b)
C  =
collagen synthesisby ﬁbroblast sitmulated by TGF−βwith collagen crowding
  
kFC FF c(Tβ) Fc(C)+
collagen degradation by M M P9
  
koff [CM9] − kon M9A C, (6)
[CM9]  = konM9A · C − konc[CM9]. (7)
The parameters used in these equations with their
biological meanings, experimental values, units, and
references were listed in Table 4. The interaction func-
tions M(Tb), Fg(Tb), and Fc(Tb), were established based
on in vivo,a n din vitro experiments [17,23-26]. We
employed the function Fc(C) in a form given by Waugh
and colleagues [27,28]. The forms of these functions we
took in this study were described in equation 8.
M(Tβ) = 0.3350T3
β − 6.3095T2
β + 32.2810Tβ + 57.3019
Fg(Tβ) = 0.0492T3
β − 0.9868T2
β + 6.5408Tβ +7 . 1 0 9 2
Fc(Tβ) = 0.0092T3
β − 0.1552T2
β + 0.6279Tβ + 0.2527
Fc(C) = −4.33 × 10−10C2 + 0.0000009C2 − 0.00055C + 0.13
(8)
Plot of these constructed functions and the available
experimental data were shown in Figure 2.
Equation 1 determines the rate of macrophage (MF)
infiltration. The function M(Tb) describes the migration
rate of macrophages to the scar tissue [17]. Since we
assumed that all monocytes differentiated into macro-
phages (assumption 1), M(Tb) also represents the migra-
tion of monocytes stimulated by TGF-b1. Parameter
dMF denotes the emigration rate of macrophages [29],
since macrophages do not die locally in the scar tissue
but emigrate to the lymph node system for disposal.
Equation 2 determines the crowding effect of myo-
cytes, endothelial cells, vascular smooth muscles cells,
fibroblasts, macrophages, and collagen in the myocar-
dium, which are affected by total environment density
[30,31]. Parameter kmem(t) = 0.17 + 0.56e−dmct denotes
the crowding effects contributed by myocytes, endothe-
lial cells, and vascular smooth muscle cells. The para-
meter 0.17 represents the total percentage of endothelial
and smooth muscle cells that account for 7% and 10%
of total cell numbers in normal mouse myocardium,
respectively [32]. Parameter 0.56 represents the percen-
tage of myocytes (56%) in normal mouse myocardium
[32]. Parameter dmc = 0.05 represents the rate of myo-
cyte cell death since ischemic myocytes undergo necro-
sis in the infarct region post-MI. The crowding effect of
macrophages, fibroblasts, and collagen was considered
by calculating the normalized density with respect to
their maximum density in scar tissue [28]. Temporal
Figure 1 A working model of post-MI scar formation and remodeling with constructive and destructive modules. Red arrows represent
the destruction pathway and green arrows represent the construction pathway. The regulation scheme includes lines in black, which can be a
driving or a triggering stimulus. LV remodeling outcomes are denoted as collagen concentrations in the scar tissue.
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tributed by macrophages, fibroblasts, and collagen, and
the parameter kmem (t) were shown in Figure 3.
Equation 3 determines the rate of fibroblast (F) den-
sity changes based on the assumption that majority of
fibroblasts come from the proliferation of resident cells
(assumption 2). The function Fg(Tb) denotes the stimu-
lating effects of TGF-b1 on the growth rate of fibroblasts
[17]. Parameter dF represents the apoptosis rate of the
fibroblast [33].
Equation 4 determines the rate of TGF-b1 concentra-
tion change, wherein kFT denotes the TGF-b1 secretion
rate of fibroblasts [34] and kMFT denotes the TGF-b1
secretion rate of macrophages [35] since a major source
of TGF-b1 in the scar tissue is the activated macro-
phage. Parameter dTb represents the degradation rate of
TGF-b1, which can be calculated from the half life data
[36].
TGF-b1 gene levels demonstrated temporal progres-
sion at the early stage post-MI. Gene expression profile
of TGF-b1 increased post-MI, peaked at day 2, and
returned to normal levels after day 7 in mice post-MI
[37]. Since majority of TGF-b1 secreted in the infarct is
activated (Assumption 3), gene expression profile can be
used as an activation pattern of TGF-b1.T h ef u n c t i o n ,
ut denotes temporal profile of TGF-b1 activation post-
MI [38-40] and works as the input in the simulation. It’s
worth to mention that TGF-b1 activation levels were
different with respect to different scar size. A temporal
profile of ut representing small scar was shown in Fig-
ure 3.
Equation 5 determines the rate of activated MMP-9
concentration change. Proteolytic collagen degradation
with activated MMP-9 is described in equation 5a,
where M9A,C ,C M 9, and CID denote activated MMP-9,
collagen, binding of MMP-9 and collagen, and degraded
collagen peptide concentration, respectively. MMP-9 is
inhibited primarily by TIMP-1, and TIMP-1 is induced
by TGF-b1. Thus, we established an inhibition function
h(T) = 1/(1+Tb/TbN)w i t hT bN =6 . 0p g / μL to represent
the inhibition effect.
Equation 6 determines the rate of collagen concentra-
tion changes. Collagen secreti o nr a t eb yf i b r o b l a s t sw a s
denoted by parameterKFC.M e a n w h i l e ,t h ef u n c t i o n ,Fc
(Tb), characterizes effects of TGF-b1 on collagen secre-
tion rate by fibroblasts [23,41]. Function, Fc(c), denotes
the effect of collagen density on fibroblast secretion rate
[27,28].
Equation 7 determines the concentration change of
CM9, based on the theoretical model for collagen degra-
dation by MMPs proposed by Popel’s group [42,43].
Computational simulations
Computational simulations of scar formation (collagen
deposition) were carried out by solving the nonlinear
differential equations with MATLAB. Initial conditions
of the fibroblast and macrophage densities were chosen
as F(0) = 20 cells/mm
3 and MF(0) = 5 cells/mm
3.
Table 4 Pre-determined parameters in the mathematical model
Symbol Biological meaning Value Units Ref
dMF Macrophage removal rate**(eqn 1) 0.6 day
-1 [29]
rMF maximal macrophage density (eqn 2) 2500 cells/mm
3 [28]
rF maximal fibroblast density(eqn 2) 1250 cells/mm
3 [28]
rC maximal collagen density (eqn 2) 3300 μg/mm
3 [28]
kF Fibroblast growth rate* (eqn 3) 0.924 day
-1 [62]
dF Fibroblast apoptosis rate (eqn 3) 0.12 day
-1 [33]
kMFT Macrophage TGF-b production rate (eqn 4) 0.07 pg/cell/day [34]
kFT Fibroblast TGF-b production rate (eqn 4) 0.004 pg/cell/day [35]
dTb TGF-b degradation rate
¥(eqn 4) 15 day
-1 [36]
KMM9 Macrophage secretion MMP9 rate (eqn 5) 3 pg/cell/day estimated
dM9 MMP-9 degradation rate(eqn 5) 0.875 day
-1 [63-65]
kon Kinetic reaction speed (eqn 5) 3 × 10
-4 1/(μg/mm
3)s
-1 [42,66,67]
koff Kinetic reaction speed (eqn 5) 4 × 10
-4 s
-1 [42,66,67]
konc Kinetic reaction speed (eqn 6) 0.004 s
-1 [42,66,67]
kFC Fibroblast collagen production rate (eqn 6) 20 μg/cell/day [41]
*The growth rate of cells was determined by the population doubling time (T2) via equation k = ln 2/T2 [68].
** Since macrophages emigrate from the scar tissue to lymph node system instead of dying locally in the scar tissue, the removal rate of macrophage, dMA,w a s
used in our model.
¥ The decaying rate of chemical factors was calculated from their half-life (T1/2) via the equation d = ln 2/T1/2 [68].
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(0) = 839.5 μg/μL, CM9(0) = 447.6 μg/μL were calcu-
lated by the equilibriums of equations 1-7 for normal
LV. All the simulations shown in this study used the
same initial conditions. The initial conditions were cho-
sen based on measurements in the normal LV for both
the control and MI groups (MI induced at day 0). The
simulations covered the LV remodeling process from
day 0 to day 30 post-MI.
Model validation
To validate our mathematical model, we compared our
simulation results to experimental data from our lab or
reported in the literature [9,12,44]. We normalized
macrophage and fibroblast cell densities and MMP-9
concentrations to the corresponding measurements in
the normal LV and plot the experimental data (Mean ±
SD) in Figure 4. Our computational simulation results
were also normalized to the corresponding initial condi-
tions. This normalization will give us the relative fold
changes of macrophage and fibroblast cell densities and
MMP-9 concentration. The simulation results showed
similar progression trend of cell densities and MMP-9
concentration profiles, peak values, and stable values as
the experimental results (Figure 4).
In addition, our simulations correctly predicted MMP-
9 responses to three TGF-b1 stimuli corresponding to
reduced, normal, and elevated post-MI activation
strength. Others have reported an early increase of
M M P - 9l e v e l so f7 8±1 9p g / μLf o rs m a l li n f a r c t sa n d
195 ± 63 pg/μL for large infarcts [45,46]. These experi-
mental results agreed with the MMP-9 predictions by
our mathematical model, which peak at 80 pg/μLf o r
small infarcts, and 220 pg/μL for large infarcts,
Figure 2 Macrophage migration rate M(Tb) [17], fibroblast growth rate Fg(Tb) [17], and fibroblast secretion rate Fc(Tb) [23,41]plotted as
functions of TGF-b1 concentration. The original experimental data (x, Mean ± SD) are shown for comparison. The function Fc(C) was provided
by Waugh et al [27,28].
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and details of the simulation setup for Figure 5 were
explained as follows.
Effects of TGF-b1 levels
We employed activation of TGF-b1, uT in equation 4, at
reduced, normal, and elevated post-MI strength. The
activation function peaked at 15, 30, and 60 pg/μL/day,
according to active expression levels observed in small,
median, and very large infarcts, respectively. Temporal
profiles of cell densities of macrophages, fibroblasts,
concentrations of MMP-9, collagen, and TGF-b1
responses to the stimuli uT are shown in Figure 5. For
the TGF-b1 stimulus level setting at 30 pg/μL/day (a
normal post-MI level in mice), TGF-b1 peaked after day
2 post-MI, macrophage density peaked at day 3, MMP-9
concentration peaked at day 4, and all were returned to
normal levels at 30 days post-MI. In contrast, fibroblast
density and collagen density continued to increase
beginning at day 4, reached a stable value after day 20
post-MI, and then remained at a higher equilibrium
level at day 30 post-MI (blue solid line in Figure 5).
This computational predictions agreed with the experi-
mental observations on the peak time of macrophages
[9,12], and progression trend of MMP-9 [10] and col-
lagen for stable LV remodeling [47].
In the case of reduced TGF-b1 levels (with an activa-
tion peak at 15 pg/μL/day in Figure 3), less monocytes
were attracted to the infarct. Thereby, less macrophages
and MMP-9 appeared at the early stage. The reduced
MMP-9 levels slowed down collagen degradation, lead-
ing to a higher collagen concentration (black dotted
lines in Figure 5. This simulation agreed with the
Figure 3 Plots of crowding effects (equation 2) and TGF-b1 activation function uT (equation 4). A: Crowding effects (kmem (t) in equation
2) contributed by myocytes, endothelial cells, and vascular smooth muscle cells. B: Crowding effects contributed by macrophages, fibroblasts,
and collagen in the scar tissue. C: Total crowding effects imposed by the environment. D: TGF-b1 activation function, uT according to small scar
size. Activation peak time is at day 2 post-MI with amplitude at 15 pg/μL/day.
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Page 7 of 14Figure 4 The relative ratio changes of fibroblast density, macrophage density, and MMP-9 concentrations. Computational results were
normalized to initial conditions and are shown in solid lines. Previously published experimental results were normalized to the corresponding
measurements in control group and are shown as x (Mean ± SD). All experiments were carried out in mice with MI induced by coronary artery
ligation. The fibroblast and macrophage densities were collected from C57BL/6J mice [12]. MMP-9 profile was collected from 129SV mice [45,46].
Figure 5 Temporal profiles of TGF-b1, macrophages, MMP-9, fibroblasts, collagen, and collagen peptides from days 0 to 30 post-MI in
response to low (····), median (blue line), and elevated (red dash) TGF-b1 stimuli. The initial conditions were set to F(0) = 20 cells/mm
3 and
MF(0) = 5 cells/mm
3,T b(0) = 0.21 pg/μL, M9A(0) = 7.1 pg/μL, C(0) = 839.5 μg/μL, CM9(0) = 447.6 μg/μL, according to measurements in normal
myocardium. The symbol ↑ indicates the peak time of TGF-b1 stimulus.
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[9,12], and relative low expression levels of MMP-9 for
moderate size of infarcts compared to large infarcts
[46,48].
When the TGF-b1 stimulus strength was elevated to a
level 2-fold higher than normally seen post-MI in mice,
more macrophages infiltrated to the infracted region in
the early days (Figure 5 red dash lines). Elevated macro-
phage infiltration led to high levels of crowding effect
and high concentrations of MMP-9 for collagen degra-
dation. Therefore, fibroblast growth was inhibited earlier
d u et ot h ec r o w d i n ge f f e c t ,w h i c hl e dt ol e s sc o l l a g e n
secretion and a net negative collagen deposition. These
results indicated an increased early susceptibility to LV
rupture between day 2 to 6 post-MI and prolonged LV
remodeling for those mice that did not rupture. Though
we know that LV ruptures frequently occurred at day 2-
4 post-MI in a normal remodeling process [49], this
simulation has not been examined experimentally and
raises some interesting hypotheses.
Effects of MMP-9 interventions on ECM destruction
With the validated parameter settings, we also used the
mathematical model to predict the effects of MMP-9
interventions at different strengths and intervention
times. Specifically, we simulated the LV remodeling
responses to three different MMP-9 interventions post-
MI: 1) elevation of MMP-9 level (200 pg/μL) beginning
at 8 hours post-MI to mimic the earlier increase of
MMP-9 levels seen with reperfusion, 2) elevation of
MMP-9 levels (200 pg/μL) beginning at 7 days post-MI
to mimic a prolonged macrophage infiltration, and 3)
reduced elevation of MMP-9 levels (100 pg/μL) begin-
ning at 7 day to mimic therapeutic targeting of MMP-9.
The LV remodeling responses were shown in Figure 6.
Early MMP-9 intervention (scenario 1) significantly
decreased collagen density at day 30 post-MI, consistent
with the beneficial effects seen with reperfusion. Ele-
vated MMP-9 levels (scenarios 1, 2, and 3) led to
reduced collagen density post-MI, compared to collagen
levels seen in LV remodeling outcomes without MMP-9
intervention, when MMP-9 levels would be starting to
fall by day 7. Compared to scenario 2, reducing MMP-9
intervention levels at day 7 post-MI (scenario 3) had
less effect on collagen degradation, suggesting that the
primary effects of MMP-9 might occur before day 7.
Discussion
This study is the first investigation to integrate mathe-
matical modeling with ECM and fibroblast gene array
data and plasma analytes to predict ECM remodeling
post-MI. We have integrated in vivo, in vitro,a n din
silico approaches to dissect the complicated interactions
among multiple regulatory factors in LV remodeling. As
such, this study provides a promising modeling
approach for elucidating the complicated LV remodeling
process. The most important findings of this study are
highlighted as follows. 1) The balance between ECM
construction and destruction kinetics is likely the key
determinant of scar formation, and interventions to
either the construction or destruction side lead to differ-
ent remodeling outcomes. 2) Dynamic interactions
among key factors in LV remodeling determine LV
remodeling outcomes post-MI. Altering initial condi-
tions, intervention strengths, or intervention times have
significant effects on LV remodeling outcomes, and
these effects could be simulated accurately by our
model. 3) Collagen, MMP-9, TGF-b1,a n dT I M P - 1a r e
critical biomarker candidates of LV remodeling
outcomes.
Our experimental results on microarray and plasma
data provided the foundations to build our computa-
tional framework. We examined 84 ECM genes and
chose the 17 genes that were most highly over-
e x p r e s s e di nt h ei n f a r c tr e g i o nc o m p a r e dt ob o t hc o n -
trol and non-infarcted groups (>2.5-fold over-expres-
sion). The expression levels of several of these factors
were further verified by our plasma data at protein level.
One interesting finding was that SPP1 (osteopontin)
gene expression levels increased 206-fold in the infarct
region compared to the control group at day 7 post-MI,
suggesting strong macrophage activation. The plasma
protein levels of osteopontin increased from 250 ± 60
ng/mL in controls to 390 ± 100 ng/mL in post-MI sam-
ples, which adds support for the critical role of macro-
phages in our mathematical model. Therefore, the
primary selection of the most highly changed genes
allowed us to focus on the most significant factors at
gene level and predict the possible interactions at pro-
tein level and cellular level.
An interesting observation was that MMP-9 mRNA
levels did not increase in our gene array analysis, but
MMP-9 protein levels increased in the plasma data. It is
well known that MMP-9 protein levels and activation
were increased at day 7 post-MI. This conflicting phe-
nomena is caused by pre-formed MMP-9 proteins
stored in leukocytes, which do not rely on increased
gene expression to induce MMP-9 secretion and activa-
tion [50]. In addition, the shift from a normal ventricle
composed of cardiac myocytes, endothelial cells, and
smooth muscle cells to an infarcted ventricle comprised
primarily of cardiac fibroblasts and inflammatory cells
could result in a quantitative no gain in gene expression
level but qualitative increase in MMP-9 function due to
increased activation and increased substrate availability.
Karl Weber’s group showed that MMP-9 protein levels
increased early post-MI, but the mRNA levels were not
elevated [51]. We have also shown that MMP-9 activa-
tion increases upon reperfusion in a dog model of
Jin et al. BMC Systems Biology 2011, 5:60
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our observations in this study and highlight the fact that
MMP-9 is primarily regulated att h ep o s t - t r a n s l a t i o n a l
level. Furthermore, the fact that MMP-9 gene levels do
n o tc h a n g ea td a y7p o s t - M Ia l s os u g g e s tt h a tM M P - 9
should be evaluated at the protein level.
There is limited data available to construct suitable
functions of M(Tb), Fg(Tb), Fc(Tb), and Fc(c). Wahl et al
presented a set of in vitro data on monocyte chemotaxis
induced by TGF-b with concentration ranges from 0.05
pg/mL to 10 pg/mL [17]. Their experiments also pro-
vided production of fibroblast growth activity induced
with TGF-b concentration range from 10 pg/mL to 10
ng/mL. These data were used in this study to construct
the functions of M (Tb)a n dFg(Tb). Roberts et al have
presented a set of data on in vitro collagen formation
stimulated by TGF-b with the concentration range from
0.0825 pg/mL to 2.5 pg/mL [23]. Ignotz and Massague
have examined the effects of TGF-b on collagenases in
chick embryo fibroblasts stimulated by TGF-b at a con-
centration range of 1.25 ng/mL to 25 ng/mL [41]. We
have done experiments to quantify the ECM production
of cardiac fibroblast stimulated with TGF-b (10 ng/mL).
These experimental data were used to build and justify
the function, Fc(Tb). Loftis and colleagues have studied
effects of collagen density on cardiac fibroblast behavior
and showed elevated fibroblast activities stimulated with
higher collagen concentrations (750 μg/mL - 1250 μg/
mL) [52]. Wu and colleagues showed that propeptides
at lower levels caused about 80% decrease in collagen
synthesis compared to control [53]. In this study, we
used an in silico function Fc(c)p r o v i d e db yW a u g ha n d
colleagues [27,28]. These experiments were done by dif-
ferent groups with different conditions and the in vitro
experiments might not reflect the in vivo interactions.
In addition, we established these functions using polyno-
mial interpolation. It’s likely that these functions are not
the optimal forms to describe the in vivo interactions;
however, they provide us a baseline for further study.
Our computational results demonstrated that altering
the strength of TGF-b1 altered LV remodeling out-
comes. Elevated TGF-b1 levels at the early stage (day 3
post-MI) led to elevated macrophage density and MMP-
9 levels, decreased fibroblast secretion of collagen and
collagen deposition, and thereby, prolonged the progres-
sion of remodeling. Wetzler and colleagues have shown
that the prolonged persistence of macrophages at the
late phase (after day 7 post-MI) impairs the wound heal-
ing process [54]. It has also been shown that elevated
TGF-b1 levels delays wound healing post-MI [55,56].
Figure 6 Temporal profiles of MMP-9, macrophages, TGF-b1, fibroblasts, collagen, and collagen peptides from days 0 to 30 post-MI at
different MMP-9 interventions. The profiles include progressive changes in response to MMP-9 intervention at day 1 (····) and day 7 (red dash),
as well as reduced MMP-9 intervention strength at day 7 post-MI (green dot-dash), and no intervention (blue line). The initial conditions were
set to F(0) = 20 cells/mm
3 and MF(0) = 5 cells/mm
3,T b(0) = 0.21 pg/μL, M9A(0) = 7.1 pg/μL, C(0) = 839.5 μg/μL, CM9(0) = 447.6 μg/μL according
to the measurements in normal myocardium.
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viously published studies.
Simulations of different TGF-b1 strengths also shed
light on the regulation scheme of ECM construction
and destruction. For ECM construction regulation,
active TGF-b1 stimulated fibroblast proliferation and
collagen secretion, which increased the crowding
effect. The increased crowding coefficient ramped
down fibroblast proliferation and TGF-b1 secretion
(negative feedback), which slowed down the stimulus
for monocytes to migrate into the infarct region. The
decrease of monocytes number led to less macrophage
infiltration, which then reduced the crowding coeffi-
cient. Meanwhile, reduced macrophages lead to less
TGF-b1 secretion by macrophage, which further slo-
wed down collagen synthesis. For collagen destruction
regulation, TGF-b1 induced macrophage infiltration,
which lead to elevated MMP-9 secretion, elevated col-
lagen degradation, and thereby reduced crowding coef-
ficients. Smaller crowding coefficients lead to elevated
fibroblast proliferation and collagen secretion. Notably,
there are two types of negative feedback schemes in
the mathematical model: degradation (apoptosis or
emigration) rates associated with proteins (cells) and
the crowding effects. Degradation rates are constants
and determine how fast the proteins (cells) can
respond to stimuli. Crowding effects are time varying
impacts imposed by the environment. Through these
regulation schemes, a dynamic balance of collagen
construction and destruction can be maintained to
generate a stable scar. Furthermore, profiles of crowd-
ing effects elucidated the transition from the normal
LV to scar tissue with respect to cell types and col-
lagen concentrations (Figure 3).
It is worth mentioning that there exist biological nega-
tive feedbacks in our mathematical model. For macro-
phage density regulation, there was a positive feedback
loop containing macrophage and TGF-b1:T G F - b1 sti-
mulated monocytes migration, leading to macrophage
infiltration; macrophages secreted TGF-b1 which might
attract more macrophages to the infarct site. We
observed elevated macrophage density and MMP-9 con-
centrations corresponding to increased TGF-b1 levels
(Figure 5). This positive feedback loop was inhibited by
emigration of macrophages and degradation of TGF-b1.
In addition, Wahl et al pointed out that the monocyte
chemotactic activity increased in response to low con-
centrations of TGF-b1 stimuli, while the chemotactic
activity decreased in response to higher concentrations
of TGF-b1 [ 1 7 ] .T h e r e f o r e ,a sT G F - b1 levels continu-
ously increased, infiltration speed of macrophages
decreased as shown in figure 2 (M(Tb)), suggesting a
secondary biological inhibition scheme of the TGF-b1 –
macrophage positive feedback loop.
There are a few limitations of the mathematical model
that resulted to a large degree from the model assump-
tions. More research is needed to address these limita-
tions and further enhance the models. First, our model
calls for accurate determination of MMP-9 activation
and inhibition functions. Complete time-course mea-
surements of TIMP-1 and the other three TIMPs (for
MMP-9 inhibition) and MMP-3 (for MMP-9 activation)
would provide additional details on the regulators of
MMP-9 function. Second, the large differences between
simulation results and experimental measurement of
MMP-9 concentrations before day 4 post-MI in Figure
4 is likely due to the effect of neutrophils, an early
source of MMP-9, indicating the need to investigate the
role of neutrophils in the early stage (days 1-5) post-MI
[7]. This inconsistency of the simulated MMP-9 concen-
trations and measurements from experimental results is
one of the approaches for us to employ more biomar-
kers and key factors in model development. Third,
Interleukin IL-1, IL-6, IL-10, and tumor necrosis factor-
a profiles need to be included to better study macro-
phage activation phenotypes [57]. Fourth, the effects of
other chemoattractants on monocyte migration on the
LV remodeling need further investigation. The predicted
fibroblast density at days 14-30 post-MI was lower than
experimental measurements. This might be caused by
assumption 2, that the increase of fibroblast numbers
post-MI was contributed solely by proliferation of local
cells. We will investigate the migration rates of fibro-
blasts in the future to refine our mathematical model.
Regardless of the above limitations, we were able to use
our model to compute the progression of macrophages,
fibroblasts, and collagen density, MMP-9 and TGF-b1
concentrations post-MI.
This systems biology study for LV remodeling can be
expanded to include proteomics and cardiac functions
in future studies. We employed plasma data in this
study since plasma proteins reflect the process of LV
remodeling and plasma data are more directly translata-
ble to the clinic. However, we are well aware that mea-
suring tissue protein levels will provide a more direct
evaluation of LV remodeling. Further investigation on
the ECM proteomics in cardiac samples has been
planned in our future research to establish a more com-
plete mathematical model for LV remodeling. Though it
is beyond the scope of the current paper, we have pre-
viously reported some data on cardiac function [58-60]
and our future study will integrate cardiac function into
the mathematical model.
The computational model for post-MI LV remodeling
developed here illustrated the dynamic interactions
among critical factors in LV remodeling. This is the first
mathematical model focusing on the protein and cellular
interactions post-MI. Thus, this model provides a strong
Jin et al. BMC Systems Biology 2011, 5:60
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hensive model that takes into account a more complete
set of parameters. The model also provides a tool to
guide experimental designs by identifying candidate fac-
tors to intervene, the proper intervention time, and
doses for effective interventions to achieve the most
beneficial outcomes. As an example, we have shown the
effects of MMP-9 intervention time and doses on LV
remodeling outcomes in this study. Though this model
was established based on in vitro data and in vivo data
from mice, the modeling approach can be used to
develop models for other scenarios such as the LV
remodeling of human MI and LV remodeling under
reperfusion conditions.
Conclusions
In conclusion, we developed a set of differential equa-
tions to quantitatively model the dynamic interactions
and temporal changes of the key components identified
from our experimental results. Predictions of the mathe-
matical model fell well within experimental measure-
ments, particularly with regard to macrophage
infiltration and matrix remodeling. This mathematical
model provides a powerful tool to better understand
how the dynamic balance between ECM construction
and ECM destruction influences LV remodeling
outcomes.
Methods
Mice
All animal procedures were conducted in accordance
with the Guide for the Care and Use of Laboratory Ani-
mals (National Research Council, 1996) and were
approved by the Institutional Animal Care and Use
Committee at the University of Texas Health Science
Center at San Antonio. Male C57BL/6J wild type adult
mice (n = 13) at age 8.0 ± 0.5 months were used. One
group (n = 6) served as unoperated controls, while the
other group (n = 7) underwent coronary artery ligation
for 7 days as described previously [9] and were sacri-
ficed at day 7 post-myocardial infarction.
In Vivo Procedures
Blood was collected from the jugular vein and placed in
a heparinized tube for plasma collection. Tissue was col-
lected for the gene array analysis as described previously
[9].
Microarray and Plasma Analysis
Total RNA was isolated using the TRIzol plus Total
RNA purification kit (Invitrogen). The RT
2 qPCR Pri-
mer Array for Extracellular Matrix and Adhesion Mole-
cules (SuperArray catalog APMM-013A) was used for
the gene array. Results were analyzed based on the
ΔΔCt method with normalization of raw data to the
GAPDH housekeeper gene. Data are presented as aver-
age 2
-ΔCT levels.
For the fibroblast ECM microarray analysis, cardiac
fibroblasts were isolated from adult C57BL/6J mice and
stimulated with or without 10 ng/ml TGF-b1 for 24
hours[61]. Plasma samples (80 μL) were analyzed for 67
antigens using the quantitative immunoassay panel for
mice provided by Rules Based Medicine in Austin, TX
(http://www.rulesbasedmedicine.com).
Statistical Analysis
Control, remote, and infarct LV groups were analyzed
by ANOVA, with the Bonferroni post hoc test. Control
and MI plasma was analyzed by Students t-test. Unsti-
mulated and TGF-b1 stimulated fibroblast groups were
analyzed by paired t-test. A p < 0.05 was considered sta-
tistically significant.
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